Feeling better is supposed to be the goal. So when you finally get there, it makes sense that stopping the medication feels like the logical next step. You don’t want to be on it longer than you need to. You feel like yourself again. You wonder if you even still need it.
That reasoning isn’t wrong, exactly. But the decision to stop antidepressants, and especially the decision to stop them on your own without tapering, doesn’t always go the way people expect. And the gap between what people think will happen and what sometimes does happen is wide enough that it’s worth understanding before you make that call.
Why people stop on their own
It’s worth starting here, because the reasons are genuinely understandable and not things to dismiss.
Some people stop because they feel better and assume the medication has done its job. Some stop because the side effects have been hard to live with and they’ve run out of patience waiting for their psychiatrist to address them. Some stop because they don’t like the idea of being on medication indefinitely, and feeling well enough to stop feels like proof that they’re ready. Some stop because life got busy and they ran out of refills and never got around to calling it in.
None of these reasons come from a place of carelessness. They come from a place of trying to manage something that has already required a lot of managing. Understanding the risks isn’t about making people feel bad for stopping. It’s about giving people the information they didn’t have when they made that call, or making sure they have it before they do.
What discontinuation syndrome actually is
When someone stops an antidepressant abruptly, particularly an SSRI or SNRI, a significant proportion will experience what’s called antidepressant discontinuation syndrome. This is not the same as withdrawal in the way people think of opioid or alcohol withdrawal. It’s not addiction. Antidepressants are not addictive in the clinical sense, meaning they don’t produce craving or compulsive use. But the brain does adapt to their presence over time, and removing them suddenly gives the brain’s neurotransmitter systems less time to readjust than they need.
The symptoms of discontinuation syndrome are specific enough to have an acronym that’s used in clinical settings: FINISH. Flu-like symptoms. Insomnia. Nausea. Imbalance and dizziness. Sensory disturbances. Hyperarousal and anxiety.
The sensory disturbances are the ones that tend to catch people off guard most. Some people describe what are called brain zaps, brief electrical shock-like sensations in the head or body. Others describe a visual disturbance where movement seems to produce a trailing effect. These are not dangerous in most cases, but they’re disorienting, and people who don’t know they can happen sometimes fear something is seriously wrong.
Symptoms typically begin within one to four days of stopping, depending on the half-life of the specific medication. Paroxetine and venlafaxine have shorter half-lives and are more commonly associated with discontinuation symptoms. Fluoxetine has a much longer half-life and its own active metabolite, which means the drug clears the body slowly enough that discontinuation symptoms are rare.
For most people, symptoms resolve within one to two weeks. For some, they last longer, particularly with certain medications or at higher doses. The severity varies considerably. Some people stop abruptly with no symptoms at all. Others have a genuinely difficult few weeks.
The harder question: is it relapse or discontinuation?
This is where things get genuinely complicated, and where not having clinical guidance creates real risk.
The symptoms of antidepressant discontinuation syndrome overlap significantly with the symptoms of depression returning. Low mood, anxiety, sleep disruption, irritability, difficulty functioning. When someone stops their medication and starts feeling worse, they’re left with a question that’s hard to answer on their own: is this the medication leaving my system, or is this my depression coming back?
The distinction matters enormously for what to do next. Discontinuation syndrome resolves on its own within weeks and does not necessarily mean the person needs to resume medication long-term. A relapse of depression means the underlying condition has returned and almost certainly warrants treatment. Confusing one for the other can lead people to either resume medication unnecessarily or fail to recognize a true relapse until it’s become more severe.
A psychiatrist can help work through this question. There are clinical indicators that help distinguish the two, including the timing of symptom onset, the specific nature of the symptoms, and the person’s history with depression. Without that guidance, the call is genuinely difficult to make.
The relapse risk is real and varies by history
Separate from discontinuation syndrome, stopping antidepressants does carry a real risk of depressive relapse, and that risk is not the same for everyone.
Research on antidepressant discontinuation consistently shows that people who stop medication are at higher risk of relapse than those who continue it, particularly in the first six to twelve months after stopping. The size of that risk depends heavily on individual history.
For someone who has had a single depressive episode that responded well to treatment, stopping after an adequate period of treatment, which current guidelines generally recommend as at least six to twelve months of continuation treatment after remission, carries a more manageable relapse risk. For someone who has had two or more depressive episodes, the risk of recurrence is meaningfully higher, and the recommendation is often longer-term maintenance treatment. For someone with three or more episodes, the data supports indefinite maintenance for many people.
This is not because antidepressants are being pushed for their own sake. It’s because recurrent depression is a recurrent condition, and the evidence shows that staying on medication substantially reduces the likelihood of another episode for people with that pattern.
Stopping medication before an adequate continuation period has elapsed, regardless of how well the person feels, meaningfully increases the risk of early relapse. Feeling well is partly a product of the medication working. Removing it before the brain has had adequate time to stabilize on its own is one of the most common drivers of early return of symptoms.
What a safe taper actually looks like
The antidote to abrupt discontinuation is a gradual taper, ideally designed by a psychiatrist who knows the specific medication, the dose, and the individual’s history.
What gradual means varies. For some medications and some people, tapering over several weeks is sufficient. For others, particularly those who are sensitive to discontinuation symptoms or who have been on higher doses for longer periods, the taper may need to be much slower, extending over months. Some people do best by switching to the longer-acting fluoxetine before tapering, which takes advantage of its pharmacological properties to smooth the process.
The key principle is that the nervous system needs time to recalibrate. The slower the taper, the more time it has. There is no universal schedule that applies to everyone, which is exactly why this decision benefits from clinical guidance rather than a general recommendation.
It’s also worth knowing that it’s acceptable to go slowly. Some people feel pressure, internal or external, to be off medication as quickly as possible. There is no clinical reason to rush a taper. The pace that produces the fewest symptoms and the most stability is the right pace, even if it takes longer than expected.
If you’ve already stopped
If you’ve already stopped your antidepressant without tapering and you’re reading this, there’s no reason to panic. Not everyone experiences significant discontinuation symptoms. Some people stop without much difficulty at all.
If you are experiencing symptoms, the most important thing is to not try to interpret them alone. Contact your psychiatrist. They can help you understand whether what you’re experiencing is likely discontinuation syndrome, whether resuming and tapering more slowly makes sense, or whether a return of depression needs to be assessed. That call is worth making.
If you stopped because the side effects were intolerable or because you felt like your concerns weren’t being addressed, that’s also worth saying out loud. Medication management is not a one-time prescription. It’s an ongoing conversation, and a psychiatrist who knows you should be responding to what’s not working.
Getting the right support
Decisions about starting, adjusting, or stopping psychiatric medication are ones that should happen with a psychiatrist who knows your history, not in isolation. That’s not about relinquishing control. It’s about having the information and the support to make a decision that’s actually in your interest.
Vantage Mental Health offers psychiatric medication management at clinics in Stillwater, Edina, and St. Anthony, and via telehealth across Minnesota. If you’re thinking about stopping your medication, or if you’ve already stopped and want to make sense of what you’re experiencing, a conversation with a psychiatrist is the right place to bring that.
Thinking About Your First Psychiatric Appointment?
If you’ve been wondering whether therapy is right for you, this is your gentle sign. Let’s figure it out together.
Contact us with questions | (651) 217-1480
Frequently Asked Questions
For most people, stopping abruptly is not medically dangerous in the way stopping certain other medications is. It won't cause seizures the way abrupt alcohol or benzodiazepine discontinuation can. But it can produce a significant and disorienting discontinuation syndrome, and it meaningfully increases the risk of depressive relapse. Dangerous is the wrong word for most cases. Inadvisable and potentially very uncomfortable is more accurate. The risk-benefit calculation of a gradual taper versus an abrupt stop almost always favors the taper.
For most people, one to two weeks. For some, particularly those on higher doses or shorter-acting medications, symptoms can persist for a month or more. Paroxetine and venlafaxine are the medications most commonly associated with prolonged discontinuation symptoms. If symptoms are lasting beyond a few weeks or are significantly affecting daily functioning, contact your psychiatrist. There are ways to manage the process that can reduce the duration and severity.
This is genuinely one of the harder questions to answer without clinical input. Some indicators point toward discontinuation: symptoms that began within days of stopping, physical symptoms like dizziness or brain zaps, a quality that feels different from previous depressive episodes. Indicators that lean toward relapse include: symptoms emerging more slowly, a pattern that resembles previous episodes of depression, the absence of physical discontinuation symptoms. A psychiatrist can help distinguish these, and the distinction matters for what comes next. When in doubt, make the call.
Not necessarily. Whether someone needs to resume medication depends on what emerges after stopping. If discontinuation syndrome resolves and depression does not return, resuming may not be necessary. If depression returns, that's a clinical situation that needs evaluation. The decision isn't predetermined. What matters is having enough support and monitoring in place after stopping to catch a relapse early if it does occur, rather than waiting until it becomes severe.
Yes. Wanting to stop medication is a reasonable and common thing to feel, and it doesn't require justification. The goal isn't to be on medication indefinitely for its own sake. The goal is to use it for as long as it's serving you and to stop in a way that minimizes the risk of what's been gained being lost. Wanting to stop and doing so thoughtfully, with your psychiatrist's involvement, are not in conflict.
That's a real situation and a legitimate reason for the decision you made. If ongoing side effects, concerns about the medication, or a sense of not being heard drove you to stop on your own, the more important conversation is about finding care where those concerns are actually addressed. Medication management shouldn't feel like something that's happening to you. It should feel collaborative. If it hasn't, that's worth naming, either with your current psychiatrist or by finding one who engages differently.
